http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010116294-A

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2010116294-A
titleOfInvention METHOD OF REJUVENATING A HUMAN ORGANISM
abstract 1. The method of rejuvenating the human body, which is pre-treated with skin growth medium, and then use autologous fibroblasts with the addition of hyaluronic acid by introducing them as intradermal injections for 1-6 courses, while the number of injection points n is selected in the range 2≤n≤12, a is also additionally orally introduced into the body of biologically active additives of the class of metabolites and chelators in one therapeutic course and at the same time, vitamin and minerals are orally administered complexes containing magnesium and calcium. ! 2. The method according to claim 1, in which, during each course, autologous fibroblast cells are injected intradermally together with hyaluronic acid in an amount of N, selected from the range (1.1≤N≤18) · l06, while the cell concentration in physiological solution C is selected within 1.5 С C С 9.2 million cells / ml, and the number of injection points n is determined in the range 2 ≤ n 12 12, with the interconnected inequality of 1.02 ((Vi + V) / V 2 2 volume ratio point injection Vi, where 1≤i≤n and the total volume of injection solution V, subject to the conditions V1 + V2 ... + Vi + ... + Vn-1 + Vn = V. ! 3. The method according to claim 2, in which the number of therapeutic courses of treatment is selected in the range of 2-4. ! 4. The method according to claim 3, in which metabolites and chelators are orally administered with therapeutic courses of treatment for 1 month with a monthly break between them. ! 5. The method according to claim 4, in which the oral administration of metabolites and chelators is alternated after 1 day. ! 6. The method according to claim 1, wherein ethylene diamine tetraacetic acid compounds are used as chelator. ! 7. The method according to claim 1, in which acetylcarnitine and alpha-l are used as metabolites
priorityDate 2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406934280

Total number of triples: 22.